www.fdanews.com/articles/149153-drug-firm-valeant-to-acquire-medicis
Drug Firm Valeant to Acquire Medicis
September 4, 2012
Valeant Pharmaceuticals International has agreed to buy Medicis Pharmaceutical for $2.6 billion, the latest in a string of acquisitions that have transformed the Canadian drug maker into a multibillion-dollar global company.
The Wall Street Journal
The Wall Street Journal